Targeting the tumor-associated vasculature therefore demonstrates an efficient approach and additionally, the cross-fire effect may contribute to the efficacy by ensuring that the irradiation reaches PSMA-low expressing tumor cells in direct proximity to the PSMA-high expressing endothelial cells counteracting a certain degree of heterogeneous radionuclide distribution [19]. This evidence concerns the gene FOLH1 and neoplasm.